Liu et al. [18] found the expression of RPL31 and RPL21 mRNA in CD34 + cells of patients with low-risk -MDS, high-risk -MDS and sAML were significantly lower than those of healthy controls and positively correlated with the levels of hemoglobin and platelet. Here, RPL21 is linked to myelodysplastic syndrome.